Skip to main content
Premium Trial:

Request an Annual Quote

454 Q4 Revenues Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 2.
 
1. CuraGen Shows That 454's Q4 Revenue Dipped 1.1 Percent, Not 16 Percent (from Feb. 1)
 
2. Illumina's Q4 Revenues Leap 163 Percent as Profits Soar (from Feb. 2)
 
3. Illumina Shares Slump 11 Percent After Firm Said '07 R&D Costs May Double Last Year's (from Feb. 2)
 
4. EU Sets Aside $650K to Hold Five Genomics Conferences in Europe (from Feb. 1)
 
5. Stratagene Says QPCR, Reagent Sales Will Drive 7-Percent Growth in Q4 Revenue (from Feb. 1)
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more